Rebecca J. Ford

机构：McMaster University

发表论文 62 篇 · 总被引 6696 次 · h-index 32

代表论文

• AMPK as a Therapeutic Target for Treating Metabolic Diseases (2017 · Trends in Endocrinology and Metabolism · 被引 630)
• Treatment of nonalcoholic fatty liver disease: role of AMPK (2016 · American Journal of Physiology-Endocrinology and Metabolism · 被引 504)
• Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis (2016 · Nature Communications · 被引 490)
• Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma (2018 · Cell Metabolism · 被引 420)
• The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels (2016 · Diabetes · 被引 391)
• Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss (2019 · Nature Metabolism · 被引 303)